Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul;54(3):211-20.
doi: 10.4103/0019-5154.55627.

Biologics in dermatologic therapy - an update

Arijit Coondoo  1
Affiliations

Biologics in dermatologic therapy - an update

Arijit Coondoo. Indian J Dermatol. 2009 Jul.

Abstract

Biologics are protein molecules which are used in various diseases to target the specific points in the immunopathogenesis of the diseases. The molecules are produced by recombinant DNA technology. The molecules bind to the specific targets without interfering wtih rest of the pathogenetic pathways. Therefore the so called 'immunosuppressives' have, although, a broader broader spectrum of action on immune system, their side-effects are also equally more. The biologics, because of their spefic action on the immune system, have very little side effects. The biologics which have revolutionized the treatment of various dermatologic diseases have been discussed here.

Keywords: Biologics; granulocyte macrophage; interferon; interleukin.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Similar articles

See all similar articles

Cited by

References

    1. Mehlis S, Gordon KB. From laboratory to clinic: Rationale for biologic therapy. Dermatol Clin. 2004;22:371–7. - PubMed
    1. Dogra A, Salonie S. Biologic therapy in psoriasis. Indian J Dermatol Venereol Leprol. 2006;72:256–65. - PubMed
    1. Lebwohl M. A clinician's paradigm in the treatment of Psoriasis. J Am Acad Derm. 2005;53:559–69. - PubMed
    1. Krueger G, Ellis CN. Psoriasis – recent advances in understanding its pathogenesis and treatment. J Am Acad Derm. 2005;53:594–600. - PubMed
    1. Kipnis CD, Myers WA, Opeola M, Gottlieb AB. Biologic treatments for Psoriasis. J Am Acad Dermatol. 2005;52:671–82. - PubMed